GSK Gsk Plc

TIDMGSK

RNS Number : 8931W

GlaxoSmithKline PLC

13 December 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                     Mr J Symonds 
====  ========================================  =================================================== 
 b)    Position/status                          Non-Executive Chairman 
====  ========================================  =================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  =================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  =================================================== 
 b)    Nature of the                            Transfer of Ordinary Shares beneficially 
        transaction                              held for Mr Symonds in his Zeneca Retirement 
                                                 Capital Plan to his personal shareholding 
                                                 account for nil consideration. 
====  ========================================  =================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ======================== 
   GBP0.00                                                               9,027 
   ====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  =============================== 
 e)    Date of the transaction                  2019-12-10 
====  ========================================  =================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  =================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQXLFFKLFZFBQ

(END) Dow Jones Newswires

December 13, 2019 11:48 ET (16:48 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024